Search
Now showing items 1-2 of 2
Significantly Reduced Genoprevalence of Vaccine-Type HPV-16/18 Infections among Vaccinated Compared to Non-Vaccinated Young Women 5.5 Years after a Bivalent HPV-16/18 Vaccine (Cervarix1) Pilot Project in Uganda
(2016)
The objective of this study was to determine the prevalence and some predictors for vaccine
and non-vaccine types of HPV infections among bivalent HPV vaccinated and non-vaccinated
young women in Uganda. This was a ...
Beliefs, perceptions and health-seeking behaviours in relation to cervical cancer: a qualitative study among women in Uganda following completion of an HPV vaccination campaign
(Global Health Action, 2016)
Background: Cervical cancer remains a leading cause of morbidity and mortality in Uganda. Despite earlier
information campaigns to introduce human papilloma virus (HPV) vaccination, which also targeted cervical
cancer, ...